© Copyright Nostre Net
Stem cell reconstructive surgery
involves the use of stem cells for the regeneration of injured or damaged cells
in the body. Continued support by government research organizations and funding
by them will explore its potential in the treatment of various diseases. The
global stem cell reconstructive market report compiled by Market Research
Future (MRFR) analyzes historical events, current and future trends, and
predicts drivers and challenges for the period of 2017 to 2023 (forecast
period).
Market Scope
The global Stem
Cell Reconstructive Market size is predicted to expand at 22.6% CAGR during
the forecast period. Primary growth drivers include the large geriatric
population, increasing incidence of patients suffering from chronic diseases,
and constant developments in stem cell technology. Large healthcare expenditure
of nations and need for alternative treatments can spur the market growth.
Product developments have constantly disrupted the market. For instance,
NuVasive launched the next generation bone graft, Attrax Putty, for U.S.
customers. It has shown remarkable progress in spinal surgeries according to clinical
trials by the company.
Large strides made in tissue
engineering and establishment of stem cell banks can further the potential of
the market. This can be used in testing of new products and conduction of
clinical trials. Development of polymetric biomaterial systems as well
automation of stem cell technologies will guide the market throughout the
forecast period.
High costs of the treatment and
strict rules against its application may hamper the global stem cell
reconstructive market growth.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/993
Key Players:
The global stem cell reconstructive
market is led by some of the fervent players including Cytori Therapeutics Inc.
(U.S), Baxter (US), Eleveflow (France), NuVasive Inc. (US), Mesoblast Ltd.
(Australia), Osiris Therapeutics, Inc. (US), TAKARA BIO INC.(Japan),
Micronit Microfluidics (Netherlands), Tigenix (Belgium), Celyad (Belgium),
Cynata (Australia), Capricor Therapeutics (Canada), Pfizer Inc. (US), Astellas
Pharma US, Inc. (US), StemCells Inc (US), Caladrius (US), and STEMCELL
Technologies Inc. (US).
Stem Cell Reconstructive
Market - Segments
By Sources: Allogeneic, Autologous (bone marrow, adipose tissue, and blood.), and
Syngeneic among other.
By Cell Types: Embryonic Stem Cell and Adult Stem Cell among others.
By Applications: Cancer, Diabetes, Traumatic Skin Defect, and Severe Burn among others.
By End-Users: Hospital and Research Institutes among others.
By Regions: Europe, North America, APAC and the Rest-of-the-World (RoW).
Regional Analysis
The
global stem cell reconstructive market report covers the trends and happenings
to affect the market across the regions of Americas, Europe, Asia Pacific
(APAC), and the Middle East & Africa (MEA).
The
Americas accounted for the largest market share due to a well developed
healthcare sector and a large patient pool. The major share of the region is
held by North America owing to large number of patients in Canada and the U.S.
High prevalence of cancer and diabetes can facilitate regional market growth.
Europe
has assumed the second position in the global stem cell reconstructive market
followed by APAC. Investments in stem cell research and identification of new
cell cultures will boost the regional stem cell reconstructive market.
Regulation of stem cell research in countries as well as funding for stem cell
embryonic cells can drive the market.
APAC
is a developing region for the market with the major demand for stem cell
reconstructive surgeries coming from Japan and Australia. Emergence of stem
cell suppliers in China, Australia, and India is evidence of the large
potential of the global stem cell reconstructive market. Public-private partnership
agreements as well as expanding product pipelines in cell-based research can
facilitate market growth.
Browse Complete
Report Details @ https://www.marketresearchfuture.com/reports/stem-cell-reconstructive-market-993
The Wall